Prostate Cancer Care Today: Earlier Detection, Better Treatment, Fewer Side Effects

Manuel Ozambela, Jr., M.D., is a urologic surgical oncologist at Baptist Health Herbert Wertheim Cancer Institute. He specializes in the treatment of cancers that arise from the genitourinary system (urinary and reproductive systems), including kidney, bladder, prostate, testicular and penile cancers. He is fluent in English and Spanish. After earning his medical degree from Harvard Medical School, Dr. Ozambela completed his urologic surgery training at Brigham and Women’s Hospital in the Harvard Program in Urology. He received both the Exceptional Resident Award and the Award in Academic Excellence for his outstanding clinical performance and academic achievements. Prior to joining Baptist Health, Dr. Ozambela completed his fellowship in urologic oncology at the University of Texas MD Anderson Cancer Center. During the fellowship, he worked with a multidisciplinary group of investigators to study rare and aggressive kidney tumors with the goal of identifying novel treatment options. He has authored multiple scientific abstracts, manuscripts and book chapters on various topics in urologic oncology. Through his research, he strives to identify new diagnostic and treatment options for genitourinary cancers, improve patient recovery after surgery and enhance his patients’ quality of life.Understanding that he often meets patients during significantly stressful moments, Dr. Ozambela takes time to talk through diagnoses and treatment options. Through excellent communication and shared decision-making, he works with his patients to create treatment plans that reflect their individual goals. Dr. Ozambela is a South Florida native and enjoys spending time with his growing family when not taking care of patients.